Skip to content

The Effect of Vitamin K Supplementation on Glucose Metabolism

The Effect of Vitamin K Supplementation on Glucose Metabolism

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00960973
Enrollment
42
Registered
2009-08-18
Start date
2009-09-30
Completion date
2010-12-31
Last updated
2011-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Prediabetic State

Keywords

vitamin K, beta cell, glucose metabolism, insulin resistance

Brief summary

The purpose of this study is to test whether vitamin K supplementation has an effect on glucose metabolism in terms of acute beta cell response.

Detailed description

Recently, many studies have reported that vitamin K metabolism is related to glucose metabolism. The suggested mechanisms connecting vitamin K metabolism and glucose metabolism, are inflammation responses and osteocalcin effect on glucose metabolism. Most of the studies have investigated fasting glucose and insulin sensitive index, few have assessed glucose-intake-stimulated responses in regard to vitamin K supplementation. The purpose of this study is to test whether vitamin K supplementation has an effect on glucose metabolism in terms of acute beta cell response using intravenous glucose tolerance test.

Interventions

Menatetrenone 30 mg, 3 times a day for 4 weeks

DRUGPlacebo

Placebo

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
20 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy male volunteer older than 20 years

Exclusion criteria

* Subjects with (a history of) diabetes * Subjects receiving medication related to diabetes or obesity * Subjects receiving warfarin

Design outcomes

Primary

MeasureTime frame
AIRg (acute insulin response to glucose) using FSIGT (frequently sampled intravenous glucose tolerance test)4 weeks later

Secondary

MeasureTime frame
beta-cell function (FSIGT)4 weeks later
disposition index (FSIGT)4 weeks later
insulin sensitivity (FSIGT)4 weeks later

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026